1. Home
  2. TECX

as 11-21-2024 4:00pm EST

$
-
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Nasdaq

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.

Founded: 2019 Country:
United States
United States
Employees: N/A City: WATERTOWN
Market Cap: 647.7M IPO Year: 2018
Target Price: $72.25 AVG Volume (30 days): 140.0K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.63 EPS Growth: N/A
52 Week Low/High: $1.40 - $48.63 Next Earning Date: 11-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

TECX Daily Stock ML Predictions

Share on Social Networks: